Welcome to LookChem.com Sign In|Join Free
  • or
1-(Benzamidomethyl)-1,2,3,4-Tetrahydroisoquinoline is a chemical compound that belongs to the class of tetrahydroisoquinolines, which are a group of organic compounds. This particular compound has a benzamidomethyl group attached to the tetrahydroisoquinoline ring, giving it a unique structure that may have potential applications in medicinal chemistry and pharmaceutical research.
Used in Pharmaceutical Research:
1-(Benzamidomethyl)-1,2,3,4-Tetrahydroisoquinoline is used as a research compound for exploring its potential interactions with biological targets such as receptors or enzymes. Its unique structure may allow it to modulate these targets, leading to the development of new therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(Benzamidomethyl)-1,2,3,4-Tetrahydroisoquinoline is used as a starting point for the design and synthesis of new drugs. Its structural features can be further modified to enhance its pharmacological properties and optimize its therapeutic potential.

55375-96-7

Post Buying Request

55375-96-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55375-96-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 55375-96-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,3,7 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 55375-96:
(7*5)+(6*5)+(5*3)+(4*7)+(3*5)+(2*9)+(1*6)=147
147 % 10 = 7
So 55375-96-7 is a valid CAS Registry Number.

55375-96-7Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AND USE THEREOF

-

Paragraph 0060-0061; 0144-0145, (2019/03/30)

Disclosed are compounds of formula (I) below or pharmaceutically acceptable salts thereof: in which each of variables R1-R6, L, m, and n is defined herein. Also disclosed are a method for treating an opioid receptor-associated condit

HETEROCYCLIC COMPOUNDS AND USE THEREOF

-

Paragraph 0061; 0105, (2019/07/23)

Disclosed are compounds of formula (I) below or pharmaceutically acceptable salts thereof:in which each of variables R 1 -R 6 , L, m, and n is defined herein. Also disclosed are a method for treating an opioid receptor-associated condition with a compound

Method for preparing (R)-praziquantel

-

Page/Page column 21, (2015/07/07)

The invention relates to a new method for preparing (R)-praziquantel. In the invention, by taking advantage of the high stereo selectivity, site selectivity and region selectivity of an enzyme, an intermediate of a pure optical and chiral (R)-praziquantel

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 55375-96-7